Diagnostics & Research
The Diagnostics & Research industry has a total of 44 stocks, with a combined market cap of $907.1 billion, total revenue of $172.71 billion and a weighted average PE ratio of 50.14.
Market Cap
907.1B
Revenue
172.71B
Profits
18.09B
PE Ratio
50.14
Profit Margin
10.47%
Dividend Yield
0.19%
44 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 249.58B | -0.50% | 2,097,555 | 46.34B |
| 2 | DHR | Danaher Corporation | 157.81B | 0.32% | 4,423,643 | 25.11B |
| 3 | NTRA | Natera, Inc. | 59.47B | 0.92% | 1,612,839 | 2.71B |
| 4 | A | Agilent Technologies, Inc. | 48.71B | -0.03% | 2,582,118 | 7.37B |
| 5 | IQV | IQVIA Holdings Inc. | 44.50B | -1.69% | 1,104,705 | 16.98B |
| 6 | WAT | Waters Corporation | 42.59B | 0.75% | 662,535 | 4.64B |
| 7 | IDXX | IDEXX Laboratories, Inc. | 40.91B | 1.14% | 331,112 | 4.55B |
| 8 | ILMN | Illumina, Inc. | 40.77B | -1.42% | 5,031,977 | 4.49B |
| 9 | MTD | Mettler-Toledo International Inc. | 30.29B | -0.49% | 129,644 | 4.13B |
| 10 | DGX | Quest Diagnostics Incorporated | 26.08B | -0.11% | 741,726 | 11.56B |
| 11 | LH | Labcorp Holdings Inc. | 25.11B | 0.22% | 821,526 | 14.35B |
| 12 | GH | Guardant Health, Inc. | 23.79B | 0.45% | 1,578,681 | 1.18B |
| 13 | MEDP | Medpace Holdings, Inc. | 17.27B | -0.28% | 229,012 | 2.78B |
| 14 | RVTY | Revvity, Inc. | 16.86B | 0.29% | 1,940,555 | 2.91B |
| 15 | CRL | Charles River Laboratories International, Inc. | 13.98B | -0.54% | 838,263 | 4.00B |
| 16 | ICLR | ICON Public Limited Company | 13.30B | -0.90% | 965,904 | 8.29B |
| 17 | QGEN | Qiagen N.V. | 9.14B | -0.85% | 1,407,971 | 2.10B |
| 18 | BLLN | BillionToOne, Inc. | 5.81B | -1.46% | 528,009 | 397.41M |
| 19 | GRAL | GRAIL, Inc. | 5.67B | 1.34% | 1,292,128 | 165.26M |
| 20 | RDNT | RadNet, Inc. | 5.57B | -0.73% | 598,672 | 2.27B |
| 21 | SHC | Sotera Health Company | 5.23B | -0.60% | 1,247,735 | 1.22B |
| 22 | ADPT | Adaptive Biotechnologies Corporation | 4.70B | -0.47% | 1,686,001 | 308.08M |
| 23 | VCYT | Veracyte, Inc. | 3.65B | -6.41% | 1,725,708 | 561.90M |
| 24 | CDNA | CareDx, Inc. | 3.29B | 3.76% | 2,351,007 | 458.09M |
| 25 | WGS | GeneDx Holdings Corp. | 2.64B | -0.09% | 510,259 | 454.43M |
| 26 | NEO | NeoGenomics, Inc. | 2.48B | -1.18% | 2,019,656 | 766.30M |
| 27 | PSNL | Personalis, Inc. | 1.76B | -0.66% | 1,016,100 | 69.67M |
| 28 | FRNM | Freenome, Inc. | 1.72B | -0.12% | 418,837 | 35.41M |
| 29 | OPK | OPKO Health, Inc. | 1.22B | - | 1,531,347 | 587.90M |
| 30 | CSTL | Castle Biosciences, Inc. | 1.09B | 1.76% | 437,681 | 357.28M |
| 31 | FLGT | Fulgent Genetics, Inc. | 610.84M | 3.02% | 246,959 | 323.93M |
| 32 | MYGN | Myriad Genetics, Inc. | 398.86M | 0.72% | 1,648,380 | 806.60M |
| 33 | BDSX | Biodesix, Inc. | 307.04M | -1.02% | 98,309 | 102.94M |
| 34 | XGN | Exagen Inc. | 211.24M | -0.23% | 281,985 | 71.12M |
| 35 | BNR | Burning Rock Biotech Limited | 196.16M | 3.33% | 39,519 | 73.70M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 128.28M | -0.76% | 313,504 | 1.67M |
| 37 | QUCY | Quantum Cyber N.V. | 115.17M | 3.01% | 498,640 | 537.08K |
| 38 | MDXH | MDxHealth SA | 53.93M | -2.89% | 236,253 | 114.02M |
| 39 | PRPO | Precipio, Inc. | 42.34M | -3.35% | 52,298 | 27.20M |
| 40 | ADVB | Advanced Biomed Inc. | 10.54M | 1.11% | 13,666 | - |
| 41 | NDRA | ENDRA Life Sciences Inc. | 9.06M | 1.85% | 37,378 | - |
| 42 | XWEL | XWELL, Inc. | 7.68M | 0.49% | 25,492 | 28.28M |
| 43 | BIAF | bioAffinity Technologies, Inc. | 4.28M | 1.28% | 128,810 | 5.90M |
| 44 | ISPC | iSpecimen Inc. | 3.17M | 0.80% | 535,315 | 466.30K |